The BIOS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BIOS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BIOS Detailed Price Forecast - CNN Money||View BIOS Detailed Summary - Google Finance|
|View BIOS Detailed Summary - Yahoo! Finance||View BIOS Stock Research & Analysis - Zacks.com|
|View BIOS Trends & Analysis - Trade-Ideas||View BIOS Major Holders - Barrons|
|View BIOS Call Transcripts - NASDAQ||View BIOS Breaking News & Analysis - Seeking Alpha|
|View BIOS Annual Report - CompanySpotlight.com||View BIOS OTC Short Report - OTCShortReport.com|
|View BIOS Fundamentals - TradeKing||View BIOS SEC Filings - Bar Chart|
|View Historical Prices for BIOS - The WSJ||View Performance/Total Return for BIOS - Morningstar|
|View the Analyst Estimates for BIOS - MarketWatch||View the Earnings History for BIOS - CNBC|
|View the BIOS Earnings - StockMarketWatch||View BIOS Buy or Sell Recommendations - MacroAxis|
|View the BIOS Bullish Patterns - American Bulls||View BIOS Short Pain Metrics - ShortPainBot.com|
|View BIOS Stock Mentions - StockTwits||View BIOS Stock Mentions - PennyStockTweets|
|View BIOS Stock Mentions - Twitter||View BIOS Investment Forum News - Investor Hub|
|View BIOS Stock Mentions - Yahoo! Message Board||View BIOS Stock Mentions - Seeking Alpha|
|View Insider Transactions for BIOS - SECform4.com||View Insider Transactions for BIOS - Insider Cow|
|View BIOS Major Holdings Summary - CNBC||View Insider Disclosure for BIOS - OTC Markets|
|View Insider Transactions for BIOS - Yahoo! Finance||View Institutional Holdings for BIOS - NASDAQ|
|View BIOS Stock Insight & Charts - FinViz.com||View BIOS Investment Charts - StockCharts.com|
|View BIOS Stock Overview & Charts - BarChart||View BIOS User Generated Charts - Trading View|
Edited Transcript of BIOS earnings conference call or presentation 15-Mar-19 1:00pm GMT
Posted on Wednesday March 20, 2019
Q4 2018 BioScrip Inc Earnings and Definitive Merger Agreement with Option Care Call
Moody's Investors Service ("Moody's") today placed the ratings of BioScrip, Inc. (BioScrip), including the Caa1 Corporate Family Rating (CFR), under review for upgrade. This follows the announcement that BioScrip will merge with HC Group Holdings III, Inc.(dba Option Care). BioScrip will issue common stock to Option Care in an all-stock deal.
BioScrip's stock extends plunge after merger terms disappoint, but analyst recommends remaining bullish
Posted on Monday March 18, 2019
Shares of BioScrip Inc. tumbled 9.0% toward a 9-month low in midday trade Monday, extending the sharp reversal suffered early in the previous session as investors digested the terms of the company's merger deal with Option Care Enterprises Inc. On Friday, the stock soared as much as 71% in premarket trade, and as much as 8.0% during the regular session, before pulling a sharp U-turn to close down 20.3%. Canaccord Genuity analyst Richard Close said that investors may have to suffer some short-term pain, given the disappointment that BioScrip shareholders will own just 20% of the post-merger company, but he remains bullish given the long-term potential. "The need for scale in health care is increasingly paramount as the provider and payer markets consolidate and reimbursement risk is always present," Close wrote in a research note. "Thus, having scale is a significant advantage as [BioScrip] seeks to negotiate rates and drive sustained operating results." The stock has tumbled 35.5% year to date, while the S&P 500 has climbed 12.7%.
BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract
Posted on Monday March 18, 2019
The combined expertise of BioScrip (BIOS) and OptionCare is expected to drive significant growth for the former.